Accuron MedTech

Sekisui Chemical, a Japanese diagnostics company, is acquiring Veredus Laboratories, a Singapore-based molecular diagnostics kit maker. The deal size was not disclosed, but market sources estimate Veredus could be worth around US$83 million.